Chronic Myocardial Ischemia Clinical Trial
Official title:
Pilot Study of Investigation of Bone Marrow-derived Mesenchymal Stem Cells (MSC) Administration in Weaning From Left Ventricular Assist Device
Left Ventricular Assist Devices are commonly used to assist failing hearts as a bridge to transplantation or for long-term support. The purpose of the MESenchymal stem cell therapy and Left Ventricular Assist Device program is to improve heart function with stem cell therapy and attempt to wean patients from HeartMate Left Ventricular Assist Device.
Currently Left Ventricular Assist Device-only patients are being implanted and followed. Feasibility of autologous mesenchymal stem cell grafting in patients receiving heart mate will be assessed in a 4 patient pilot trial. Mesenchymal stem cell are delivered during Left Ventricular Assist Device surgery by intramyocardial infusions. Recovery of contractile function of the heart is assessed during attempts to wean patients from Left Ventricular Assist Device ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00221182 -
Stem Cell Study for Patients With Heart Disease
|
Phase 1/Phase 2 | |
| Completed |
NCT01076920 -
Mesenchymal Stem Cells and Myocardial Ischemia
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03455725 -
CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial
|
N/A | |
| Completed |
NCT02462330 -
Administration of Mesenchymal Stem Cells in Patients With Chronic Ischemic Cardiomyopathy (MESAMI2)
|
Phase 2 | |
| Completed |
NCT02059681 -
Phase I Trial of Endocavitary Injection of Bone Marrow Derived CD133+ Cells in Ischemic Refractory Cardiomyopathy (RECARDIO Trial)
|
Phase 1 | |
| Recruiting |
NCT01267331 -
Cell Therapy in Patients With Chronic Ischemic Heart Disease Undergoing Cardiac Surgery
|
Phase 1/Phase 2 | |
| Completed |
NCT01454323 -
Intracoronary Infusion of Bone Marrow Mononuclear Cells in Patients With Previous Myocardial Infarction.
|
Phase 2 | |
| Completed |
NCT01508910 -
Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina
|
Phase 3 |